SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes

[Display omitted] •Stereotactic MR-guided online adaptive radiotherapy (SMART) as personalized therapy.•SMART of 26 patients with 31 abdominopelvic, oligoprogressive lymphatic metastases.•Increased planning target volume (PTV) coverage due to plan adaptation (+7%).•Avoidance of overdoses to organs-a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiotherapy and oncology 2022-03, Vol.168, p.106-112
Hauptverfasser: Regnery, Sebastian, Buchele, Carolin, Piskorski, Lars, Weykamp, Fabian, Held, Thomas, Eichkorn, Tanja, Rippke, Carolin, Katharina Renkamp, C., Klüter, Sebastian, Ristau, Jonas, König, Laila, Koerber, Stefan A., Adeberg, Sebastian, Debus, Jürgen, Hörner-Rieber, Juliane
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Stereotactic MR-guided online adaptive radiotherapy (SMART) as personalized therapy.•SMART of 26 patients with 31 abdominopelvic, oligoprogressive lymphatic metastases.•Increased planning target volume (PTV) coverage due to plan adaptation (+7%).•Avoidance of overdoses to organs-at-risk (OAR) (19% before,
ISSN:0167-8140
1879-0887
DOI:10.1016/j.radonc.2022.01.038